Loading
Total declarations
Company
▲ Purchases (64 ops.)
▼ Sales (0 ops.)
Latest filing published 28 May 2025 for Fusen Pharmaceutical Co. Ltd.. Read the official filing
Filing timeline
BuySaleCao Zhiming
Insider track record
Disclosed buys
64
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
64
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Cao Zhiming: trading record in brief
Cao Zhiming discloses dealings in Fusen Pharmaceutical Co. Ltd. to HKEX. We count 64 filings; the first trade dates from 7 December 2021 and the latest from 23 May 2025.
The open-market record is one-sided, with 64 purchases worth €3.6M and not one sale. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2025 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €20k.
On 28 May 2025 came the latest disclosure, an open-market purchase in Fusen Pharmaceutical Co. Ltd. Filings reach the HKEX feed a median of 3 days after the trade. Until a filing is published, the market cannot know about the trade. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Companies and markets linked to Cao Zhiming
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations64 total
180,180,000 sharesShareXHKGHKEX:DA20250528E00439
Canonical exit: 21 Aug 2025 (T+90)
240,000 shares@ HK$0.8833ShareXHKGHKEX:DA20240423E00427
Canonical exit: 17 Jul 2024 (T+90)
265,000 shares@ HK$0.8442ShareXHKGHKEX:DA20240422E00418
Canonical exit: 16 Jul 2024 (T+90)
803,000 shares@ HK$1.259ShareXHKGHKEX:DA20230331E00005
Canonical exit: 27 Jun 2023 (T+90)
273,000 shares@ HK$1.3745ShareXHKGHKEX:DA20221229E00304
Canonical exit: 28 Mar 2023 (T+90)
152,000 shares@ HK$1.4676ShareXHKGHKEX:DA20221228E00330
Canonical exit: 23 Mar 2023 (T+90)
90,000 shares@ HK$1.4854ShareXHKGHKEX:DA20221228E00321
Canonical exit: 22 Mar 2023 (T+90)
195,000 shares@ HK$1.4711ShareXHKGHKEX:DA20221223E00234
Canonical exit: 21 Mar 2023 (T+90)
248,000 shares@ HK$1.3916ShareXHKGHKEX:DA20221222E00132
Canonical exit: 20 Mar 2023 (T+90)
205,000 shares@ HK$1.4697ShareXHKGHKEX:DA20221222E00121
Canonical exit: 19 Mar 2023 (T+90)
200,000 shares@ HK$1.02ShareXHKGHKEX:DA20221108E00324
Canonical exit: 2 Feb 2023 (T+90)
2,139,000 shares@ HK$1.0491ShareXHKGHKEX:DA20221107E00591
Canonical exit: 1 Feb 2023 (T+90)
161,000 shares@ HK$0.9593ShareXHKGHKEX:DA20221024E00337
Canonical exit: 18 Jan 2023 (T+90)
2,036,000 shares@ HK$0.97ShareXHKGHKEX:DA20221020E00534
Canonical exit: 16 Jan 2023 (T+90)
852,000 shares@ HK$0.9689ShareXHKGHKEX:DA20221018E00576
Canonical exit: 12 Jan 2023 (T+90)
91,000 shares@ HK$0.9488ShareXHKGHKEX:DA20221017E00459
Canonical exit: 11 Jan 2023 (T+90)
63,000 shares@ HK$0.9492ShareXHKGHKEX:DA20221014E00150
Canonical exit: 10 Jan 2023 (T+90)
2,180,000 shares@ HK$0.95ShareXHKGHKEX:DA20221013E00366
Canonical exit: 9 Jan 2023 (T+90)
237,000 shares@ HK$0.95ShareXHKGHKEX:DA20221012E00016
Canonical exit: 8 Jan 2023 (T+90)
101,000 shares@ HK$0.949ShareXHKGHKEX:DA20221010E00380
Canonical exit: 5 Jan 2023 (T+90)
696,000 shares@ HK$0.9453ShareXHKGHKEX:DA20221006E00456
Canonical exit: 3 Jan 2023 (T+90)
275,000 shares@ HK$0.9489ShareXHKGHKEX:DA20221006E00100
Canonical exit: 1 Jan 2023 (T+90)
25,000 shares@ HK$0.95ShareXHKGHKEX:DA20220930E00482
Canonical exit: 28 Dec 2022 (T+90)
112,000 shares@ HK$0.95ShareXHKGHKEX:DA20220929E00405
Canonical exit: 27 Dec 2022 (T+90)
253,000 shares@ HK$0.946ShareXHKGHKEX:DA20220927E00349
Canonical exit: 25 Dec 2022 (T+90)
25 of 64 declarations
